Skip to content
← Full study record

NCT02804750 · MORE INFO

Limitations, agreements, and source contact

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome · Source last updated 2019-10-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
Corcept Therapeutics as the Sponsor, has a proprietary interest in this study. Authorship and manuscript composition will reflect joint cooperation between multiple Investigators and sites and Corcept Therapeutics personnel. Authorship will be established before writing of the manuscript. Because this study involves multiple centers, no individual publications will be allowed before completion of the final report of the multicenter study except as agreed with Corcept Therapeutics.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
info@corcept.com
organization
Corcept Therapeutics
phone
650-327-3270
title
Medical Director
Complete source fields
certain Agreement
other Details
Corcept Therapeutics as the Sponsor, has a proprietary interest in this study. Authorship and manuscript composition will reflect joint cooperation between multiple Investigators and sites and Corcept Therapeutics personnel. Authorship will be established before writing of the manuscript. Because this study involves multiple centers, no individual publications will be allowed before completion of the final report of the multicenter study except as agreed with Corcept Therapeutics.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
info@corcept.com
organization
Corcept Therapeutics
phone
650-327-3270
title
Medical Director

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice